Artera

About:

Artera develops multimodal artificial intelligence-based predictive and prognostic cancer tests to customize treatments for cancer patients.

Website: https://artera.ai

Twitter/X: arteraAI

Top Investors: Coatue, EDBI, Koch Disruptive Technologies, Breyer Capital, Jeff Dean

Description:

Artera develops medical artificial intelligence tests that personalize therapy for cancer patients. Its tests predict therapeutic benefits and prognosticate patient outcomes. The Artera platform is purely software, and runs on digital images of H&E histopathology images as part of routine clinical care.

Total Funding Amount:

$110M

Headquarters Location:

Los Altos, California, United States

Founded Date:

2021-01-01

Founders:

Andre Esteva, Felix Feng

Number of Employees:

101-250

Last Funding Date:

2024-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai